President Donald Trump withdrew Dr. Casey Means as his nominee for surgeon general on Thursday and announced he would nominate Dr. Nicole Saphier, a breast-cancer imaging specialist and Fox News contributor, to the post instead. The move came after months of stalled confirmation proceedings that Trump blamed squarely on Sen. Bill Cassidy, the Louisiana Republican who chairs the Senate Health, Education, Labor and Pensions Committee.

Trump made the announcement in a series of Truth Social posts Thursday afternoon, calling Saphier "a STAR physician who has spent her career guiding women facing breast cancer" and "an INCREDIBLE COMMUNICATOR, who makes complicated health issues more easily understood by all Americans." He thanked Means and said she "will continue to fight for MAHA on the many important health issues facing our country."

The swap marks the latest example of a Trump nomination running aground in a Senate where even slim Republican majorities cannot always guarantee smooth confirmations. It also signals that the White House is willing to move quickly to keep its health-policy agenda on track rather than wage a prolonged confirmation fight over a nominee who drew bipartisan skepticism.

Why Means's nomination collapsed

Means, a Stanford-trained physician who left her surgical residency before completing it, was nominated last year. Her confirmation hearing before the HELP Committee took place several months ago, but the committee never advanced her nomination to a full Senate vote. During the hearing, Republican Sens. Susan Collins of Maine and Lisa Murkowski of Alaska appeared skeptical of Means's answers on vaccines, particularly the newborn hepatitis B vaccine, and on birth control access.

Democrats, meanwhile, pointed to what they described as several financial conflicts of interest between Means and wellness companies, a line of attack tied to her financial disclosure filings. Means had co-authored Good Energy, a book on metabolic health, with her brother Calley Means, who serves as a senior White House health policy adviser.

Cassidy, himself a physician, never publicly embraced the nomination. Trump did not mince words about the chairman's role in the delay, calling Cassidy "a very disloyal person" who "stood in the way of" Means's confirmation through "intransigence and political games." The Washington Examiner reported that it contacted Cassidy's office for comment.

The friction between Trump and Cassidy is not new. Cassidy voted to impeach Trump following the Jan. 6, 2021, protests at the Capitol, a vote that placed him permanently on the president's list of Republican adversaries. This spring, Trump endorsed Rep. Julia Letlow, a Louisiana Republican, in what amounted to a direct challenge to Cassidy's standing in his home state. The MAHA Action super PAC, aligned with the administration's health and wellness movement, also backed Letlow.

Cassidy has also clashed repeatedly with Health and Human Services Secretary Robert F. Kennedy Jr. on vaccine policy and abortion-related issues, a running conflict that has complicated multiple health nominations. Intra-party tensions over Trump-aligned nominees have become a recurring theme in this Congress, and the surgeon general fight is the latest flashpoint.

Kennedy fires back

Kennedy did not hide his displeasure. In a social media post dated April 30, the HHS secretary praised Means as "one of the MAHA movement's most powerful evangelists" and took direct aim at Cassidy. Kennedy wrote that the senator:

"once again did the dirty work for the entrenched interests seeking to stall the MAHA movement and protect the very status quo that has made America the sickest nation on earth."

Calley Means was even blunter, lambasting Cassidy on social media after the withdrawal. He accused the senator of having "worked to delay her and smear her" and said Cassidy had intentionally pushed the confirmation timeline close to Casey Means's due date.

The senior White House health adviser added that Cassidy is "a mindless avatar for his donors and a blind defender of the status quo system that is profiting from American sickness." Whatever the merits of that characterization, the raw anger from inside the administration tells you how deeply the MAHA faction felt invested in Means's nomination, and how personally they took its failure.

Who is Nicole Saphier?

Saphier brings a markedly different profile to the nomination. She currently serves as Director of Breast Imaging at Memorial Sloan Kettering Cancer Center in New Jersey and sits on the CDC's Advisory Committee on Breast Cancer in Young Women. She completed a fellowship in cancer-related imaging at the Mayo Clinic, credentials that are harder for Senate skeptics to dismiss than those of a physician who never finished residency.

She is also a Fox News medical contributor, a role that has given her a national platform but also a paper trail. During the COVID-19 pandemic, Saphier co-wrote a Wall Street Journal editorial with Dr. Marty Makary, now the FDA commissioner, on the question of vaccinating children against the virus. That editorial placed both physicians in the camp that questioned blanket pediatric COVID vaccination, a position that was controversial at the time but has since gained wider acceptance.

Saphier's record is not without complications. In 2023, she drew backlash from the CDC after posting on social media that the agency was instituting a COVID-19 vaccine mandate for children. CDC officials responded that the agency could only make recommendations and that state and local jurisdictions established mandates. Means herself had once described some of her own earlier health stances as "woo-woo," so neither nominee arrived without baggage.

The nomination of a Fox News contributor to a senior government post fits a broader pattern in the Trump administration. National Review reported that Trump named Jeanine Pirro, another longtime Fox News personality, as interim U.S. attorney for the District of Columbia on May 8, 2025, after withdrawing Ed Martin's nomination when his Senate confirmation lacked sufficient support. The president has shown a consistent preference for public communicators who can make the case for his agenda beyond the Beltway.

The confirmation math ahead

The question now is whether Saphier can clear the same committee that stalled Means. Cassidy still holds the gavel, and the dynamics that sank the first nominee, vaccine skepticism concerns from Collins and Murkowski, Democratic opposition, and Cassidy's own reluctance, have not disappeared. Saphier's more conventional medical credentials may ease some of those concerns, but her public commentary on COVID vaccines and her CDC dust-up will almost certainly come up in any hearing.

Trump's willingness to move on from Means rather than force a prolonged fight suggests the White House calculated that the surgeon general post was worth more than the political cost of defending a nominee who had become a liability. Recent party-line confirmation votes on other Trump nominees have shown that the administration can push appointees through when it has the votes, but it needs the votes first.

Cassidy, for his part, now faces a primary season with a president who has publicly branded him disloyal and endorsed a rival. Whether that pressure makes him more cooperative on the Saphier nomination or more entrenched remains an open question. With the GOP's Senate majority already thin, every confirmation fight carries real cost, and Republicans can ill afford to spend months fighting each other while the administration's health agenda sits in limbo.

What it means for MAHA

The surgeon general post carries limited statutory authority compared to the HHS secretary or FDA commissioner, but it holds outsized influence as a public-health bully pulpit. The MAHA movement, Make America Healthy Again, has staked its credibility on challenging the medical establishment's approach to chronic disease, metabolic health, and pharmaceutical influence. Losing Means, one of the movement's most visible advocates, is a real setback for that cause.

Saphier is not an outsider crusader in the Means mold. She is a credentialed specialist at one of the country's premier cancer centers, with mainstream institutional affiliations. That may make her easier to confirm. It may also make her a less aggressive champion of the systemic reforms Kennedy and the Means siblings have pushed.

The administration appears to have decided that getting someone confirmed matters more than getting the perfect ideological fit. That is a pragmatic call. Whether it satisfies the grassroots health-reform constituency that rallied behind Means is another matter entirely.

Washington has a way of grinding down nominees who lack the credentials or the political armor to survive a Senate gauntlet. The lesson here is straightforward: bold agendas still need confirmable people to carry them out.